HUE062439T2 - Eljárás nagy tisztaságú terápiás csont szerek elõállítására - Google Patents

Eljárás nagy tisztaságú terápiás csont szerek elõállítására

Info

Publication number
HUE062439T2
HUE062439T2 HUE14852866A HUE14852866A HUE062439T2 HU E062439 T2 HUE062439 T2 HU E062439T2 HU E14852866 A HUE14852866 A HU E14852866A HU E14852866 A HUE14852866 A HU E14852866A HU E062439 T2 HUE062439 T2 HU E062439T2
Authority
HU
Hungary
Prior art keywords
high purity
preparing high
therapeutic bone
bone agents
purity therapeutic
Prior art date
Application number
HUE14852866A
Other languages
English (en)
Inventor
Jaime Simon
R Keith Frank
David A Wilson
Original Assignee
Igl Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igl Pharma Inc filed Critical Igl Pharma Inc
Publication of HUE062439T2 publication Critical patent/HUE062439T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/02Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes in nuclear reactors
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0094Other isotopes not provided for in the groups listed above
HUE14852866A 2013-10-07 2014-10-07 Eljárás nagy tisztaságú terápiás csont szerek elõállítására HUE062439T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361887603P 2013-10-07 2013-10-07

Publications (1)

Publication Number Publication Date
HUE062439T2 true HUE062439T2 (hu) 2023-11-28

Family

ID=52813560

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14852866A HUE062439T2 (hu) 2013-10-07 2014-10-07 Eljárás nagy tisztaságú terápiás csont szerek elõállítására

Country Status (12)

Country Link
US (2) US10172965B2 (hu)
EP (1) EP3054996B1 (hu)
JP (2) JP6787781B2 (hu)
CA (1) CA2926652C (hu)
DK (1) DK3054996T3 (hu)
ES (1) ES2949277T3 (hu)
FI (1) FI3054996T3 (hu)
HU (1) HUE062439T2 (hu)
PL (1) PL3054996T3 (hu)
PT (1) PT3054996T (hu)
SI (1) SI3054996T1 (hu)
WO (1) WO2015054173A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3302496B1 (en) * 2015-05-25 2021-01-06 IGL Pharma, Inc. Dotmp kit formulations for radioisotopes
US11369700B2 (en) * 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
EP3579886A4 (en) * 2017-02-08 2020-11-25 IGL Pharma, Inc. METHOD OF USE FOR THERAPEUTIC BONE ASSOCIATION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898724A (en) 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US5059412A (en) 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
AU2002364552A1 (en) * 2001-12-13 2003-06-30 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
JP2006508939A (ja) * 2002-10-29 2006-03-16 エンジーン, インコーポレイテッド 癌処置のための組成物
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
AR053579A1 (es) * 2005-04-15 2007-05-09 Genentech Inc Tratamiento de la enfermedad inflamatoria intestinal (eii)
EP2298308B1 (en) 2005-11-14 2013-01-16 University Of Southern California Integrin-binding small molecules
WO2011149844A1 (en) 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone

Also Published As

Publication number Publication date
US10172965B2 (en) 2019-01-08
CA2926652A1 (en) 2015-04-16
PT3054996T (pt) 2023-08-01
JP6787781B2 (ja) 2020-11-18
CA2926652C (en) 2021-07-20
JP7068222B2 (ja) 2022-05-16
ES2949277T3 (es) 2023-09-27
JP2016532652A (ja) 2016-10-20
JP2019123731A (ja) 2019-07-25
FI3054996T3 (fi) 2023-08-31
US10596277B2 (en) 2020-03-24
SI3054996T1 (sl) 2023-11-30
EP3054996A4 (en) 2017-07-05
DK3054996T3 (da) 2023-07-10
PL3054996T3 (pl) 2023-09-18
US20190083661A1 (en) 2019-03-21
EP3054996B1 (en) 2023-06-21
EP3054996A1 (en) 2016-08-17
WO2015054173A1 (en) 2015-04-16
US20160250359A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
HK1211470A1 (en) Process for preparing therapeutic nanoparticles
HRP20181122T1 (hr) Postupak za pripremu jopamidola
IL245474A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IL245476B (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IL245649A0 (en) A process for the preparation of ragdanosone
HK1223853A1 (zh) 骨質疏鬆症治療劑
EP2967655A4 (en) PROCESS FOR THE CREATION OF BONE CAVITIES FOR BONE HEALING
EP2870929C0 (en) Surgical attachment device
ZA201401073B (en) Process for preparing atazanavir sulphate
IL243455B (en) A process for the preparation of fluoxastrobin
HUE062439T2 (hu) Eljárás nagy tisztaságú terápiás csont szerek elõállítására
IL229326A (en) Process for making n-iodine-affluent
GB201308466D0 (en) Improved process for treatment of minewater
IL242897A0 (en) A process for the preparation of pyridylpyrazole compounds and their derivatives from pyridylhydrazine
HK1200874A1 (en) Process for preparing insulin
IL239815A0 (en) Process for preparing derivatives of 4-methylpent-3-en-1-ol
GB201307348D0 (en) Garment for therapeutic treatment
IL244646A0 (en) Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbaldehyde
IL244700A0 (en) Process for preparing gabapentin
IL246188A0 (en) A process for the preparation of tiacomycin
IL239993A0 (en) Process for preparing 5-fluoro-1-methyl-3-difluoromethyl-h1-pyrazole-4-carbaldehyde
HK1200873A1 (en) Process for preparing insulin
GB201317565D0 (en) Apparatus for patient adjustment